Literature DB >> 8538221

Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis?

K A Sepkowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8538221     DOI: 10.4065/71.1.102

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  6 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

2.  Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.

Authors:  Wen-Ling Ye; Nan Tang; Yu-Bing Wen; Hang Li; Min-Xi Li; Bin Du; Xue-Mei Li
Journal:  Int Urol Nephrol       Date:  2016-06-28       Impact factor: 2.370

3.  An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.

Authors:  L J Worth; M J Dooley; J F Seymour; L Mileshkin; M A Slavin; K A Thursky
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

4.  The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.

Authors:  Ahmad Riyad Alsayed; Wamidh Talib; Abdullah Al-Dulaimi; Safa Daoud; Mohammed Al Maqbali
Journal:  Bosn J Basic Med Sci       Date:  2022-09-16       Impact factor: 3.759

5.  Three cases of presumed pneumocystis pneumonia in patients receiving bortezomib therapy for multiple myeloma.

Authors:  Christopher D Swan; Alistair B Reid
Journal:  IDCases       Date:  2014-05-29

Review 6.  Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity.

Authors:  Vickie R Shannon; Ronald Anderson; Ada Blidner; Jennifer Choi; Tim Cooksley; Michael Dougan; Ilya Glezerman; Pamela Ginex; Monica Girotra; Dipti Gupta; Douglas B Johnson; Maria E Suarez-Almazor; Bernardo L Rapoport
Journal:  Support Care Cancer       Date:  2020-09-03       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.